Drugs	Region	Rule Definitions	Rule for Subtype	Predictions	Reference
Asunaprevir	NS3	36A	1a	possibly resistant	McPhee et al. 2012
Asunaprevir	NS3	36A	1b	possibly resistant	McPhee et al. 2012
Asunaprevir	NS3	36L	1a	possibly resistant	McPhee et al. 2012
Asunaprevir	NS3	36L	1b	possibly resistant	McPhee et al. 2012
Asunaprevir	NS3	36M	1a	possibly resistant	McPhee et al. 2013; Jensen et al. 2015
Asunaprevir	NS3	36M	1b	possibly resistant	McPhee et al. 2012
Asunaprevir	NS3	41R and 80R	1b	possibly resistant	McPhee et al. 2012
Asunaprevir	NS3	80K	1b	possibly resistant	McPhee et al. 2012
Asunaprevir	NS3	155K	1a	resistant	McPhee et al. 2013; Jensen et al. 2015
Asunaprevir	NS3	155K	1b	resistant	McPhee et al. 2012
Asunaprevir	NS3	156S	1b	possibly resistant	McPhee et al. 2012
Asunaprevir	NS3	156T	1b	possibly resistant	McPhee et al. 2012
Asunaprevir	NS3	156V	1b	possibly resistant	McPhee et al. 2012
Asunaprevir	NS3	168A	1a	resistant	McPhee et al. 2012
Asunaprevir	NS3	168A	1b	resistant	McPhee et al. 2012
Asunaprevir	NS3	168C	1b	resistant	McPhee et al. 2012
Asunaprevir	NS3	168E	1a	resistant	McPhee et al. 2012; Jensen et al. 2015
Asunaprevir	NS3	168E	1b	resistant	McPhee et al. 2012
Asunaprevir	NS3	168G	1a	possibly resistant	McPhee et al. 2012
Asunaprevir	NS3	168G	1b	resistant	McPhee et al. 2012
Asunaprevir	NS3	168H	1a	resistant	Jensen et al. 2015
Asunaprevir	NS3	168H	1b	resistant	McPhee et al. 2012
Asunaprevir	NS3	168T	1a	resistant	McPhee et al. 2013
Asunaprevir	NS3	168V	1a	resistant	McPhee et al. 2013
Asunaprevir	NS3	168V	1a	resistant	McPhee et al. 2012
Asunaprevir	NS3	168V	1b	resistant	McPhee et al. 2012; Jensen et al. 2015
Asunaprevir	NS3	168Y	1a	resistant	McPhee et al. 2013
Asunaprevir	NS3	168Y	1a	resistant	McPhee et al. 2012
Asunaprevir	NS3	168Y	1b	resistant	McPhee et al. 2012
					
Boceprevir	NS3	36A	1	resistant	Ogert et al. 2013; Barnard et al. 2013; Lenz et al. 2010; Susser et al. 2009
Boceprevir	NS3	36G	1	resistant	Ogert et al. 2013; Susser et al. 2009
Boceprevir	NS3	36L	1	resistant	Ogert et al. 2013; Lenz et al. 2010
Boceprevir	NS3	36M	1	resistant	Barnard et al. 2013; Lenz et al. 2010; Tong et al. 2008; Zhou et al. 2008; Lagacé; et al. 2012
Boceprevir	NS3	41R	1	possibly resistant	Tong et al. 2008; Lagacé; et al. 2012
Boceprevir	NS3	43S	1	possibly resistant	Lenz et al. 2010; Tong et al. 2008; Lagacé; et al. 2012
Boceprevir	NS3	43V	1	possibly resistant	Lenz et al. 2010; Lagacé; et al. 2012
Boceprevir	NS3	54A	1	possibly resistant	Barnard et al. 2013; Susser et al. 2009; Lenz et al. 2010; Tong et al. 2008; Lagacé; et al. 2012
Boceprevir	NS3	54C	1	resistant	Ogert et al. 2013; Barnard et al. 2013
Boceprevir	NS3	54G	1	resistant	Barnard et al. 2013; Wyles 2012; http://www.idsociety.org/uploadedFiles/IDSA/Hepatitis_C/For_IDSA_Members/ForumforCollaborativeHIV-ClinicallyRelevantHCVDrug.pdf
Boceprevir	NS3	54S	1	resistant	Ogert et al. 2013; Barnard et al. 2013; Lenz et al. 2010; Susser et al. 2009; Bae et al. 2010
Boceprevir	NS3	55A	1	resistant	Ogert et al. 2013; Barnard et al. 2013; Susser et al. 2009; Wyles 2012; http://www.idsociety.org/uploadedFiles/IDSA/Hepatitis_C/For_IDSA_Members/ForumforCollaborativeHIV-ClinicallyRelevantHCVDrug.pdf
Boceprevir	NS3	155G	1	resistant	Lenz et al. 2010
Boceprevir	NS3	155I	1	resistant	Ogert et al. 2013; Lenz et al. 2010
Boceprevir	NS3	155K	1	resistant	Susser et al. 2009; Lenz et al. 2010; Tong et al. 2008; Lagacé; et al. 2012
Boceprevir	NS3	155M	1	resistant	Ogert et al. 2013; Lenz et al. 2010
Boceprevir	NS3	155T	1	resistant	Ogert et al. 2013; Barnard et al. 2013; Susser et al. 2009; Lenz et al. 2010
Boceprevir	NS3	156G	1	possibly resistant	Lenz et al. 2010
Boceprevir	NS3	156S	1	resistant	Ogert et al. 2013; Barnard et al. 2013; Tong et al. 2008; Susser et al. 2009; Lenz et al. 2010
Boceprevir	NS3	156T	1	resistant	Ogert et al. 2013; Barnard et al. 2013; Tong et al. 2008; Lenz et al. 2010; Lagacé; et al. 2012
Boceprevir	NS3	156V	1	resistant	Barnard et al. 2013; Lenz et al. 2010
Boceprevir	NS3	168N	1	possibly resistant	Barnard et al. 2013; Lenz et al. 2010
Boceprevir	NS3	168Y	1	possibly resistant	Lenz et al. 2010
Boceprevir	NS3	170A	1	resistant	Ogert et al. 2013; Barnard et al. 2013; Lenz et al. 2010; Tong et al. 2008; Susser et al. 2009
Boceprevir	NS3	170T	1	possibly resistant	Ogert et al. 2013; Barnard et al. 2013; Lenz et al. 2010; Susser et al. 2009
Boceprevir	NS3	174F	1	resistant	Susser S, Schelhorn S, Lange C, et al. Ultratiefe Pyrosequenz-Analyse (UDPS) von neu beschriebenen seltenen Resistenzvarianten der Hepatitis C Virus NS3 Protease bei Patienten, die mit Telaprevir oder Boceprevir behandelt wurden. Z Gastroenterol 2012; 50.
					
Grazoprevir	NS3	36A	1b	possibly resistant	Howe et al. 2014
Grazoprevir	NS3	36L	1b	possibly resistant	Howe et al. 2014
Grazoprevir	NS3	36M	1a	possibly resistant	Howe et al. 2014
Grazoprevir	NS3	36M	1b	possibly resistant	Howe et al. 2014
Grazoprevir	NS3	155G	1b	resistant	Howe et al. 2014
Grazoprevir	NS3	155K	1a	possibly resistant	Howe et al. 2014
Grazoprevir	NS3	156T	1a	resistant	Forns 2015; Sulkowski 2015
Grazoprevir	NS3	156T	1b	resistant	Howe et al. 2014
Grazoprevir	NS3	168A	1a	resistant	Howe et al. 2014
Grazoprevir	NS3	168A	1b	resistant	Howe et al. 2014
Grazoprevir	NS3	168E	1a	resistant	Howe et al. 2014
Grazoprevir	NS3	168E	1b	possibly resistant	Howe et al. 2014
Grazoprevir	NS3	168G	1a	resistant	Howe et al. 2014
Grazoprevir	NS3	168G	1b	resistant	Howe et al. 2014
Grazoprevir	NS3	168K	1b	resistant	Howe et al. 2014
Grazoprevir	NS3	168N	1a	resistant	Forns 2015
Grazoprevir	NS3	168V	1a	resistant	Zeuzem 2015
Grazoprevir	NS3	168any	1	possibly resistant	Scientific committee of g2p HCV
Grazoprevir	NS3	170I	1b	possibly resistant	Forns 2015; Sulkowski 2015; Zeuzem 2015
					
Paritaprevir	NS3	36A	1a	possibly resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003839/WC500183997.pdf
Paritaprevir	NS3	36M	1a	possibly resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003839/WC500183997.pdf
Paritaprevir	NS3	43L	1a	resistant	Pilot-Matias et al. 2015
Paritaprevir	NS3	155C	4a	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003839/WC500183997.pdf
Paritaprevir	NS3	155K	1a	resistant	Pilot-Matias et al. 2015; Sulkowski et al. 2015
Paritaprevir	NS3	155K	1a, 4a, 5a	possibly resistant	Jensen et al. 2015
Paritaprevir	NS3	155Q	1a	possibly resistant	Jensen et al. 2015
Paritaprevir	NS3	156T	1a	possibly resistant	Pilot-Matias et al. 2015
Paritaprevir	NS3	156T	4a	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003839/WC500183997.pdf
Paritaprevir	NS3	156V	4a	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003839/WC500183997.pdf
Paritaprevir	NS3	168A	1a, 2a, 4, 5a, 6a	resistant	Jensen et al. 2015
Paritaprevir	NS3	168A or 168H or 168E or 168N or 168Y	1a	resistant	Pilot-Matias et al. 2015
Paritaprevir	NS3	168A or 168H or 168T or 168Y	1b	resistant	Pilot-Matias et al. 2015
Paritaprevir	NS3	168E	1b	possibly resistant	Pilot-Matias et al. 2015
Paritaprevir	NS3	168E	1b, 5a	possibly resistant	Jensen et al. 2015
Paritaprevir	NS3	168E	6a	possibly resistant	Jensen et al. 2015
Paritaprevir	NS3	168H	4a	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003839/WC500183997.pdf
Paritaprevir	NS3	168H	2a	possibly resistant	Jensen et al. 2015
Paritaprevir	NS3	168H	5a	resistant	Jensen et al. 2015
Paritaprevir	NS3	168V	1a	resistant	Lawitz et al. 2013; Pilot-Matias et al. 2015
Paritaprevir	NS3	168V	1b	resistant	Chayama et al. 2015
Paritaprevir	NS3	168V	2a, 5a, 6a	resistant	Jensen et al. 2015
Paritaprevir	NS3	168V	4	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003839/WC500183997.pdf
					
Simeprevir	NS3	36A	1	possibly resistant	Lenz et al. 2010
Simeprevir	NS3	36L	1	possibly resistant	Lenz et al. 2010; Lenz et al. 2013
Simeprevir	NS3	36M	1	possibly resistant	Lenz et al. 2010
Simeprevir	NS3	43I	1	resistant	Lenz et al. 2010
Simeprevir	NS3	43S	1	resistant	Lenz et al. 2010; Lagacé; et al. 2012
Simeprevir	NS3	43V	1	resistant	Lenz et al. 2010; Lagacé; et al. 2012
Simeprevir	NS3	80H	1	possibly resistant	Lenz et al. 2010
Simeprevir	NS3	80K	1	resistant	Fried et al. 2013; Bae et al. 2010; Lenz et al. 2013
Simeprevir	NS3	80R	1	possibly resistant	Lenz et al. 2010; Lagacé; et al. 2012
Simeprevir	NS3	122R	1	resistant	Forns et al. 2014; Lenz et al. 2013
Simeprevir	NS3	138T	1	possibly resistant	Lenz et al. 2010
Simeprevir	NS3	155G	1	resistant	Lenz et al. 2010
Simeprevir	NS3	155K	1	resistant	Fried et al. 2013; Lenz et al. 2010; Lagacé; et al. 2012
Simeprevir	NS3	155Q	1	resistant	Lenz et al. 2010; Lagacé; et al. 2012
Simeprevir	NS3	155T	1	resistant	Lenz et al. 2010
Simeprevir	NS3	156G	1	resistant	Lenz et al. 2010
Simeprevir	NS3	156T	1	resistant	Lenz et al. 2010; Lagacé; et al. 2012
Simeprevir	NS3	156V	1	resistant	Lenz et al. 2010
Simeprevir	NS3	168A	1	resistant	Forns et al. 2014; Lenz et al. 2010; Lagacé; et al. 2012
Simeprevir	NS3	168E	1	resistant	Forns et al. 2014; Lenz et al. 2010; Lenz et al. 2013
Simeprevir	NS3	168G	1	possibly resistant	Lenz et al. 2010
Simeprevir	NS3	168H	1	resistant	Lenz et al. 2015; Lenz et al. 2010
Simeprevir	NS3	168I	1	resistant	Lenz et al. 2010
Simeprevir	NS3	168N	1	possibly resistant	Lenz et al. 2010
Simeprevir	NS3	168Q	1	resistant	Lenz et al. 2013
Simeprevir	NS3	168T	1	resistant	Forns et al. 2014; Lenz et al. 2010
Simeprevir	NS3	168V	1, 4	resistant	Fried et al. 2013; Manns et al. 2014; Forns et al. 2014; Lenz et al. 2010; Lagacé; et al. 2012
Simeprevir	NS3	168Y	1	resistant	Lenz et al. 2010
Simeprevir	NS3	170T	1	resistant	Lenz et al. 2010
					
Telaprevir	NS3	36A	1	resistant	Sarrazin et al. 2007; Hézode et al. 2009; Zhou et al. 2008; Kieffer et al. 2007; Kieffer et al. 2012
Telaprevir	NS3	36G	1	resistant	Sullivan et al. 2013; Zhou et al. 2008; Kieffer et al. 2012
Telaprevir	NS3	36L	1	possibly resistant	Sullivan et al. 2013; Lenz et al. 2010; Zhou et al. 2008; Kieffer et al. 2012
Telaprevir	NS3	36M	1	resistant	Sarrazin et al. 2007; Kieffer et al. 2007; Hézode et al. 2009; Lenz et al. 2010; Sarrazin et al. 2007; Tong et al. 2008; Zhou et al. 2008; Kieffer et al. 2012; Kieffer et al. 2012; Lagacé; et al. 2012
Telaprevir	NS3	43S	1	possibly resistant	Lenz et al. 2010; Tong et al. 2008; Lagacé; et al. 2012
Telaprevir	NS3	54A	1	possibly resistant	Sarrazin et al. 2007; Kieffer et al. 2007; Hézode et al. 2009; Lenz et al. 2010; Sarrazin et al. 2007; Tong et al. 2008; Zhou et al. 2008; He et al. 2008; Kieffer et al. 2012; Lagacé; et al. 2012
Telaprevir	NS3	54S	1	possibly resistant	Sullivan et al. 2013; Susser et al. 2009; Bae et al. 2010; Kieffer et al. 2012
Telaprevir	NS3	55A	1	possibly resistant	Susser et al. 2009
Telaprevir	NS3	117H	1	possibly resistant	Susser S, Schelhorn S, Lange C, et al. Ultratiefe Pyrosequenz-Analyse (UDPS) von neu beschriebenen seltenen Resistenzvarianten der Hepatitis C Virus NS3 Protease bei Patienten, die mit Telaprevir oder Boceprevir behandelt wurden. Z Gastroenterol 2012; 50.
Telaprevir	NS3	155G	1	resistant	Lenz et al. 2010; Kieffer et al. 2012
Telaprevir	NS3	155K	1	resistant	Sarrazin et al. 2007; Kieffer et al. 2007; Hézode et al. 2009; Lenz et al. 2010; Tong et al. 2008; He et al. 2008; Kieffer et al. 2012; Lagacé; et al. 2012
Telaprevir	NS3	155M	1	resistant	Sullivan et al. 2013; Lenz et al. 2010; Kieffer et al. 2012
Telaprevir	NS3	155Q	1	possibly resistant	He et al. 2008; Lenz et al. 2010
Telaprevir	NS3	155T	1	resistant	Sarrazin et al. 2007; Kieffer et al. 2007; Hézode et al. 2009; Lenz et al. 2010; Kieffer et al. 2012
Telaprevir	NS3	156F	1	resistant	Kieffer et al. 2012
Telaprevir	NS3	156N	1	resistant	Sullivan et al. 2013; Kieffer et al. 2012
Telaprevir	NS3	156S	1	resistant	Sarrazin et al. 2007; Kieffer et al. 2007; Hézode et al. 2009; Lin et al. 2004; Sarrazin et al. 2007; Tong et al. 2008; Susser et al. 2009; He et al. 2008; Lenz et al. 2010; Kieffer et al. 2012
Telaprevir	NS3	156T	1	resistant	Sarrazin et al. 2007; Kieffer et al. 2007; Hézode et al. 2009; Lin et al. 2005; Tong et al. 2008; He et al. 2008; Lenz et al. 2010; Kieffer et al. 2012
Telaprevir	NS3	156V	1	resistant	Sarrazin et al. 2007; Kieffer et al. 2007; Hézode et al. 2009; Lin et al. 2005; He et al. 2008; Lenz et al. 2010; Kieffer et al. 2012
Telaprevir	NS3	170A	1	possibly resistant	Tong et al. 2008; Susser et al. 2009; He et al. 2008
Telaprevir	NS3	174F	1	possibly resistant	Susser S, Schelhorn S, Lange C, et al. Ultratiefe Pyrosequenz-Analyse (UDPS) von neu beschriebenen seltenen Resistenzvarianten der Hepatitis C Virus NS3 Protease bei Patienten, die mit Telaprevir oder Boceprevir behandelt wurden. Z Gastroenterol 2012; 50.
Telaprevir	NS3	174S	1a	possibly resistant	
					
Daclatasvir	NS5A	28A	1b	possibly resistant	Lok et al. 2014
Daclatasvir	NS5A	28M and 30H	4a	resistant	Zhou et al. 2016
Daclatasvir	NS5A	28S	2a	possibly resistant	Fridell et al. 2011; O'Boyle et al. 2013
Daclatasvir	NS5A	28T	1a	resistant	Wong et al. 2013
Daclatasvir	NS5A	30D	1a	resistant	Wang et al. 2012
Daclatasvir	NS5A	30E	1a, 4a	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003768/WC500172848.pdf
Daclatasvir	NS5A	30H	4	resistant	Zhou et al. 2016
Daclatasvir	NS5A	30H	1a, 4a	resistant	Wong et al. 2013
Daclatasvir	NS5A	30H	4a	resistant	Wong et al. 2013
Daclatasvir	NS5A	30K	3a	resistant	Hernandez et al. 2013
Daclatasvir	NS5A	30K	1a	resistant	Wang et al. 2012
Daclatasvir	NS5A	30K	1a	resistant	Wong et al. 2013; McPhee et al. 2013
Daclatasvir	NS5A	30R	1a, 4a	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003768/WC500172848.pdf
Daclatasvir	NS5A	30S	4	resistant	Zhou et al. 2016
Daclatasvir	NS5A	31F	3a	resistant	Wang et al. 2013
Daclatasvir	NS5A	31I	1b	possibly resistant	McPhee et al. 2014
Daclatasvir	NS5A	31M	1b	possibly resistant	Murakami et al. 2014
Daclatasvir	NS5A	31M	1a	resistant	Wong et al. 2013; McPhee et al. 2013
Daclatasvir	NS5A	31M	3a	resistant	Hernandez et al. 2013
Daclatasvir	NS5A	31V	1b	possibly resistant	McPhee et al. 2014
Daclatasvir	NS5A	31V	1a	resistant	McPhee et al. 2013
Daclatasvir	NS5A	31V	3a	resistant	Hernandez et al. 2013
Daclatasvir	NS5A	32L	1b	resistant	Wang et al. 2012
Daclatasvir	NS5A	32 del	1b	resistant	McPhee et al. 2014
Daclatasvir	NS5A	58D	1a	resistant	Lok et al. 2014; Wong et al. 2013
Daclatasvir	NS5A	92K	1b	possibly resistant	McPhee et al. 2014
Daclatasvir	NS5A	93C	1a	resistant	Wong et al. 2013; McPhee et al. 2013
Daclatasvir	NS5A	93H	1b	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003768/WC500172848.pdf
Daclatasvir	NS5A	93H	1b, 4a	resistant	Murakami et al. 2014
Daclatasvir	NS5A	93H	1a	resistant	Wong et al. 2013
Daclatasvir	NS5A	93H	3a	resistant	Hernandez et al. 2013; Wang et al. 2013
Daclatasvir	NS5A	93N	1b	resistant	Lok et al. 2014
Daclatasvir	NS5A	93R	4a	possibly resistant	
Daclatasvir	NS5A	93W	4	resistant	Zhou et al. 2016
					
Elbasvir	NS5A	30H	1a	resistant	Coburn 2013;Forns 2015; Sulkowski 2015; Zeuzem 2015
Elbasvir	NS5A	30K	3	resistant	Liu et al. 2015
Elbasvir	NS5A	30R	1a	resistant	Coburn 2013;Forns 2015; Sulkowski 2015; Zeuzem 2015
Elbasvir	NS5A	31F	1a	resistant	Coburn et al. 2013
Elbasvir	NS5A	31F	1b	resistant	Coburn 2013;Forns 2015; Sulkowski 2015; Zeuzem 2015
Elbasvir	NS5A	31F	3	resistant	Liu et al. 2015
Elbasvir	NS5A	31M	1b	resistant	Forns 2015; Sulkowski 2015; Zeuzem 2015
Elbasvir	NS5A	31V	1a	resistant	Coburn et al. 2013
Elbasvir	NS5A	93C	1a	resistant	Coburn et al. 2013
Elbasvir	NS5A	93H	1a	resistant	Coburn 2013;Forns 2015; Sulkowski 2015; Zeuzem 2015
Elbasvir	NS5A	93H	1b	resistant	Coburn 2013;Forns 2015; Sulkowski 2015; Zeuzem 2015
Elbasvir	NS5A	93H	3	resistant	Liu et al. 2015
Elbasvir	NS5A	93N	1a	resistant	Forns 2015; Sulkowski 2015; Zeuzem 2015
					
Ledipasvir	NS5A	28A	1a	resistant	
Ledipasvir	NS5A	28T	1a	resistant	Wong et al. 2013; Lawitz et al. 2012
Ledipasvir	NS5A	30E	1a	resistant	Wong et al. 2013
Ledipasvir	NS5A	30H	4	resistant	Zhou et al. 2016
Ledipasvir	NS5A	30H	1a	resistant	Wong et al. 2013; Lawitz et al. 2012
Ledipasvir	NS5A	30K	1a, 3	resistant	Hernandez et al. 2013
Ledipasvir	NS5A	30R	1a	resistant	Wong et al. 2013
Ledipasvir	NS5A	30S	4	resistant	Zhou et al. 2016
Ledipasvir	NS5A	31I	1a	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003850/WC500177995.pdf
Ledipasvir	NS5A	31M	1a	resistant	Afdhal et al. 2014; Wong et al. 2013
Ledipasvir	NS5A	31M and 28M	1b	resistant	Newton (CROI)
Ledipasvir	NS5A	31V	1a	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003850/WC500177995.pdf
Ledipasvir	NS5A	32L	1a	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003850/WC500177995.pdf
Ledipasvir	NS5A	32 del	1	possibly resistant	Scientific committee of g2p HCV
Ledipasvir	NS5A	58D	1a	resistant	Wong et al. 2013
Ledipasvir	NS5A	58D	1b	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003850/WC500177995.pdf
Ledipasvir	NS5A	92K	1b	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003850/WC500177995.pdf
Ledipasvir	NS5A	93C	1a	resistant	Wong et al. 2013; Lawitz et al. 2012
Ledipasvir	NS5A	93H	1a, 1b	resistant	Osinusi et al. 2015; Wong et al. 2013; Lawitz et al. 2012
Ledipasvir	NS5A	93H	3	resistant	Hernandez et al. 2013
Ledipasvir	NS5A	93H	1a	resistant	Wong et al. 2013
Ledipasvir	NS5A	93N	1a	resistant	Wong et al. 2013
Ledipasvir	NS5A	93S	1b	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003850/WC500177995.pdf
Ledipasvir	NS5A	93T	1a	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003850/WC500177995.pdf
Ledipasvir	NS5A	93W	4	resistant	Zhou et al. 2016
					
Ombitasvir	NS5A	28M and 31F	1b	resistant	Krishnan et al. 2015
Ombitasvir	NS5A	28S and 31I	4	possibly resistant	Hezode, presentation at ILC/EASL 2014
Ombitasvir	NS5A	28T	1a	resistant	Krishnan et al. 2015
Ombitasvir	NS5A	28T	1b	resistant	Krishnan et al. 2015
Ombitasvir	NS5A	28V	1a	possibly resistant	Krishnan et al. 2015; Zeuzem et al. 2014
Ombitasvir	NS5A	28V	4 (except 4d)	possibly resistant	Krishnan et al. 2015
Ombitasvir	NS5A	28V	4d	resistant	Schnell et al. 2015
Ombitasvir	NS5A	28V and 31F	1b	resistant	Krishnan et al. 2015
Ombitasvir	NS5A	30E	1a	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003839/WC500183997.pdf
Ombitasvir	NS5A	30R	1a	resistant	Krishnan et al. 2015; Zeuzem et al. 2014
Ombitasvir	NS5A	31F	1b	possibly resistant	Krishnan et al. 2015
Ombitasvir	NS5A	31V	1a	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003839/WC500183997.pdf
Ombitasvir	NS5A	31V	1b	possibly resistant	Krishnan et al. 2015
Ombitasvir	NS5A	32 del	1, 4	possibly resistant	McPhee et al. 2014
Ombitasvir	NS5A	58D	1a	resistant	Krishnan et al. 2015
Ombitasvir	NS5A	93C	1a	resistant	Krishnan et al. 2015
Ombitasvir	NS5A	93H	1a	resistant	Krishnan et al. 2015
Ombitasvir	NS5A	93H	1b	resistant	Krishnan et al. 2015; Zeuzem et al. 2014
Ombitasvir	NS5A	93N	1a	resistant	Krishnan et al. 2015
Ombitasvir	NS5A	93S	1a	resistant	Krishnan et al. 2015
					
Dasabuvir	NS5B	316N	1b	possibly resistant	Kati et al. 2015; Zeuzem, presentation at ILC/EASL 2014
Dasabuvir	NS5B	316Y	1a, 1b	resistant	Kati et al. 2015
Dasabuvir	NS5B	368T	1b	resistant	Kati et al. 2015
Dasabuvir	NS5B	395G	1a	possibly resistant	Kati et al. 2015
Dasabuvir	NS5B	411S	1b	resistant	Kati et al. 2015
Dasabuvir	NS5B	414I	1a, 1b	possibly resistant	Kati et al. 2015; http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003839/WC500183997.pdf
Dasabuvir	NS5B	414T	1a, 1b	resistant	Kati et al. 2015
Dasabuvir	NS5B	444K	1a	possibly resistant	Kati et al. 2015
Dasabuvir	NS5B	445F and 451S and 585V	1b	possibly resistant	Kati et al. 2015
Dasabuvir	NS5B	448C	1a, 1b	resistant	Kati et al. 2015
Dasabuvir	NS5B	448H	1a, 1b	resistant	Kati et al. 2015
Dasabuvir	NS5B	553T	1a	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003837/WC500182233.pdf
Dasabuvir	NS5B	553V	1a, 1b	resistant	Kati et al. 2015; http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003839/WC500183997.pdf
Dasabuvir	NS5B	554S	1a	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003837/WC500182233.pdf
Dasabuvir	NS5B	556G	1a, 1b	resistant	Kati et al. 2015; Zeuzem et al. 2014; Feld, presentation at ILC/EASL 2014; Zeuzem, presentation at ILC/EASL 2014
Dasabuvir	NS5B	556N	1a	resistant	Kati et al. 2015
Dasabuvir	NS5B	556R	1a	resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003837/WC500182233.pdf
Dasabuvir	NS5B	557R	1	possibly resistant	Kwo, presentation at ILC/EASL 2014 (study M12-999)
Dasabuvir	NS5B	558R	1a	possibly resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003837/WC500182233.pdf
Dasabuvir	NS5B	559G	1a	possibly resistant	Kati et al. 2015
Dasabuvir	NS5B	559N	1a	possibly resistant	Feld, presentation at ILC/EASL 2014
Dasabuvir	NS5B	561H	1a	possibly resistant	http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003837/WC500182233.pdf; Feld, presentation at ILC/EASL 2014
Dasabuvir	NS5B	565F	1a	possibly resistant	Kati et al. 2015
					
Sofosbuvir	NS5B	159F	1a, 1b, 2b, 3a	possibly resistant	Donaldson et al. 2015; Svarovskaia et al. 2014
Sofosbuvir	NS5B	282R	1a	possibly resistant	Donaldson et al. 2015
Sofosbuvir	NS5B	282T	2a	resistant	Svarovskaia et al. 2014
Sofosbuvir	NS5B	282T	1a, 1b	resistant	Lam et al. 2012
Sofosbuvir	NS5B	282T	3, 4, 5, 6, 7	possibly resistant	Lam et al. 2012
Sofosbuvir	NS5B	289L	2a	possibly resistant	Lam et al. 2012
Sofosbuvir	NS5B	321A	3a	possibly resistant	Donaldson et al. 2015; Svarovskaia et al. 2014
